These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 12819295

  • 1. CREATE: new strategies for early anaemia management in renal insufficiency.
    Macdougall IC, Steering Committee of the CREATE trial, CREATE Study Group.
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 2():ii13-6. PubMed ID: 12819295
    [Abstract] [Full Text] [Related]

  • 2. New strategies in anaemia management: ACORD (Anaemia CORrection in Diabetes) trial.
    Laville M, Anaemia CORrection in Diabetes trial.
    Acta Diabetol; 2004 Mar; 41 Suppl 1():S18-22. PubMed ID: 15103544
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R, Epoetin Zeta Study Group.
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [Abstract] [Full Text] [Related]

  • 4. Epoetin beta (NeoRecormon) corrects anaemia in patients with hormone-refractory prostate cancer and bone metastases.
    Bogdanos J, Karamanolakis D, Milathianakis K, Repousis P, Chloraki-Bobota A, Majed H, Pagalou-Thoua E, Tsintavis A, Koutsilieris M.
    Anticancer Res; 2004 Mar; 24(3b):1957-61. PubMed ID: 15274384
    [Abstract] [Full Text] [Related]

  • 5. Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study.
    Heras P, Kritikos K, Hatzopoulos A, Mitsibounas D.
    Eur J Cancer Care (Engl); 2008 Nov; 17(6):619-23. PubMed ID: 18707619
    [Abstract] [Full Text] [Related]

  • 6. Anemia and cardiovascular risk: the lesson of the CREATE Trial.
    Locatelli F, Del Vecchio L, Pozzoni P.
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S262-6. PubMed ID: 17130272
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of anaemia management in renal insufficiency and cardiac disease.
    Silverberg D.
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 2():ii7-12. PubMed ID: 12819294
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.
    Klinger M, Arias M, Vargemezis V, Besarab A, Sulowicz W, Gerntholtz T, Ciechanowski K, Dougherty FC, Beyer U.
    Am J Kidney Dis; 2007 Dec; 50(6):989-1000. PubMed ID: 18037099
    [Abstract] [Full Text] [Related]

  • 9. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W, Locatelli F, Ryckelynck JP, Balla J, Csiky B, Harris K, Ehrhard P, Beyer U, PROTOS Study Investigators.
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [Abstract] [Full Text] [Related]

  • 10. Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years.
    Jacobs C, Frei D, Perkins AC.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii3-24. PubMed ID: 15824128
    [Abstract] [Full Text] [Related]

  • 11. Extended epoetin alfa dosing in chronic kidney disease patients: a retrospective review.
    Germain M, Ram CV, Bhaduri S, Tang KL, Klausner M, Curzi M.
    Nephrol Dial Transplant; 2005 Oct; 20(10):2146-52. PubMed ID: 15985516
    [Abstract] [Full Text] [Related]

  • 12. [Guidelines for the treatment of anemia in chronic renal failure].
    Triolo G, Italian Society of Nephrology.
    G Ital Nefrol; 2003 Oct; 20 Suppl 24():S61-82. PubMed ID: 14666504
    [Abstract] [Full Text] [Related]

  • 13. Epoetin delta is effective for the management of anaemia associated with chronic kidney disease.
    Spinowitz BS, Pratt RD, Epoetin Delta 2002 Study Group.
    Curr Med Res Opin; 2006 Dec; 22(12):2507-13. PubMed ID: 17166333
    [Abstract] [Full Text] [Related]

  • 14. Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality?
    Abaterusso C, Pertica N, Lupo A, Ortalda V, Gambaro G.
    Diabetes Obes Metab; 2008 Sep; 10(10):843-9. PubMed ID: 18093210
    [Abstract] [Full Text] [Related]

  • 15. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B, van de Werf PR, Melissant CF, Brok RG.
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [Abstract] [Full Text] [Related]

  • 16. Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients.
    Kwan JT, Pratt RD, Epoetin Delta Study Group.
    Curr Med Res Opin; 2007 Feb; 23(2):307-11. PubMed ID: 17288685
    [Abstract] [Full Text] [Related]

  • 17. The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin beta in peritoneal dialysis patients with chronic renal anaemia.
    Grzeszczak W, Sulowicz W, Rutkowski B, de Vecchi AF, Scanziani R, Durand PY, Bajo A, Vargemezis V, European Collaborative Group.
    Nephrol Dial Transplant; 2005 May; 20(5):936-44. PubMed ID: 15769814
    [Abstract] [Full Text] [Related]

  • 18. Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: a subgroup analysis of the NeoPrevent study.
    de Castro J, Belda-Iniesta C, Isla D, Dómine M, Sánchez A, Batiste E, Barón MG.
    Lung Cancer; 2008 Feb; 59(2):211-8. PubMed ID: 17875340
    [Abstract] [Full Text] [Related]

  • 19. Early intervention with epoetin beta prevents severe anaemia in patients with solid tumours receiving platinum-based chemotherapy: results of the NeoPrevent study.
    de Castro J, Ordóñez A, Isla D, Sánchez A, Arrivi A, Manzano JL, Barón MG.
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):35-42. PubMed ID: 16874498
    [Abstract] [Full Text] [Related]

  • 20. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N, Sriuranpong V.
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.